VBI Vaccines Announces Second Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma Patients
pharmaceutical investing VBI Vaccines Announces Dosing of First Patient in Phase 1/2a Clinical Study of VBI-1901
pharmaceutical investing VBI Vaccines Hepatitis B Data Selected as Presidential Poster of Distinction
Metalsource Mining Receives $1.38 Million from Eric Sprott Warrant Exercise as Silver Hill Gold-Silver Exploration Advances
SAGA Metals Reports More Significant Assays Including 109.1 m at 49.88% Fe2O3, 8.53% TiO2, 0.316% V2O5 at the Radar Critical Minerals Project
Syntholene Energy Corp. Announces $3.5 Million Strategic Private Placement Led by Director and Co-Founder Canon Bryan